With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

If you're using GLP-1 medications like Ozempic, Wegovy, or Mounjaro, you know how important it is to prioritize protein ...

If you're looking for a meal that’s quick, flavorful, and packed with protein, these Spicy Sriracha Lime Shrimp Bowls ar ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...

When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

(HealthDay News) — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online in ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).